Takeda Pharmaceutical Co Ltd ADR (TAK)

13.49
+0.12(+0.90%)
Pre Market
13.52
+0.03(+0.22%)
- Real-time Data
  • Volume:
    2,181,849
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    13.40 - 13.52

TAK Overview

Prev. Close
13.37
Day's Range
13.4-13.52
Revenue
3.02T
Open
13.5
52 wk Range
13.17-19.96
EPS
1.33
Volume
2,181,849
Market Cap
42.52B
Dividend (Yield)
0.80
(5.96%)
Average Vol. (3m)
2,531,268
P/E Ratio
10.16
Beta
0.97
1-Year Change
-28.05%
Shares Outstanding
1,557,494,154
Next Earnings Date
Feb 03, 2022
What is your sentiment on Takeda Pharmaceutical Co Ltd ADR?
or
Market is currently closed. Voting is open during market hours.

Takeda Pharmaceutical Co Ltd ADR Company Profile

Employees
47099

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Albumin/Flexbumin, Ninlaro, and Alunbrig brands. Takeda Pharmaceutical Company has licensing agreements with Denali Therapeutics and Wave Life Sciences Ltd; collaboration agreements with Neurocrine Biosciences, Inc. and Rani Therapeutics LLC; license and research agreements with The University of Texas MD Anderson Cancer Center, Poseida Therapeutics, Inc., and Arrowhead Pharmaceuticals Inc.; research collaboration agreements with Arrowhead Pharmaceuticals Inc. and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; HemoShear Therapeutics, LLC; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyNeutralStrong BuyStrong SellStrong Sell
SummaryStrong BuyBuyStrong BuyStrong SellStrong Sell
  • Which is P/E Ratio of TAK?
    0
    • PE Ratio (TTM) 15.44 from another source
      0
  • What's going on? I thought this share wll be 12 $
    2
    • what happened to the FDA decision 🤔
      0
      • FDA decision tommorrow
        0
        • Dividend yield shows as 1.22 (8.16%), I believe this is incorrect information as both NasdaqCom and Finviz + Yahoo Finance show a Yield of  4.13% and 4.84% respectively  - I don't understand why so much incongruence between sources, is anyone able to explain? Thanks!
          0
          • could be related to the way it is calculated (taking into account the last available price vs average of last 12months)
            0
        • ARK bought 1.2 Million yesterday
          0
          • this is going up..volume doubled in the last two days
            0
            • What's going on guys?
              0
              • It's going to 21$ soon
                0
                • oh~
                  0
                  • Dengue and Covid have similar incubation times and some shared symptoms. we'll need testing to differentiate.
                    0
                    • Phase III Four Complex Dengue trial response appears robust, and successful thus far. The FDA vax is proven not successful (dangerous) for populations 15 yrs and younger. Takeda's solution covers all age ranges in two doses.
                      0
                      • bullish
                        0
                        • any news ? please TAKEDA is it worths to entry ?
                          0
                          • hello Mr. Davaa do you think Takeda is for short investment ? what do you advise please ?
                            0
                            • Davaa Battsogtthank you so  much I think next week I will entry . If I need any opinion can I ask you again ? thank you so much for your very kind advises and opinions appreciated so much.
                              0
                            • SS SS Thank you. I'm not strong on stock market but I progress by little step.
                              0
                            • Davaa Battsogtok lets focus in Takeda . if you have any other advise or opinion please let me know your opinion will be highly appreciated so much . Szilike.
                              0
                          • Japanese mentality doesn't lie never.
                            0
                            • hello
                              0
                              • Takeda leads the run of COV19 Vax.Soon will be 100+
                                0
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.